 BEDMER, N.J., May 03, 2022 GLOBE NEWSWIRE -- Matinas BioPharma NYSE AMER: MTNB, a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal LNC platform technology, announced today that Jerry Jabbour, Chief Executive Officer, has been invited to present at the 12th Annual BioNJ BioPartnering Conference, co-sponsored by J.P. Morgan and JJ Innovation, being held virtually May 9-13, 2022. 